0001665160-22-002919.txt : 20221115 0001665160-22-002919.hdr.sgml : 20221115 20221115134429 ACCESSION NUMBER: 0001665160-22-002919 CONFORMED SUBMISSION TYPE: C/A PUBLIC DOCUMENT COUNT: 1 FILED AS OF DATE: 20221115 DATE AS OF CHANGE: 20221115 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Sollievo Pharmaceuticals, Inc CENTRAL INDEX KEY: 0001940381 IRS NUMBER: 824744127 STATE OF INCORPORATION: CA FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: C/A SEC ACT: 1933 Act SEC FILE NUMBER: 020-30645 FILM NUMBER: 221390438 BUSINESS ADDRESS: STREET 1: 32452 SPYGLASS COURT CITY: SAN JUAN CAPISTRANO STATE: CA ZIP: 92675 BUSINESS PHONE: (858) 243-0417 MAIL ADDRESS: STREET 1: 32452 SPYGLASS COURT CITY: SAN JUAN CAPISTRANO STATE: CA ZIP: 92675 C/A 1 primary_doc.xml C/A 0001940381 XXXXXXXX 020-30645 LIVE false false false true Issuer is extending campaign end date. Sollievo Pharmaceuticals, Inc Corporation CA 02-23-2018 32452 SPYGLASS COURT SAN JUAN CAPISTRANO CA 92675 http://sollievopharm.com N StartEngine Capital, LLC 0001665160 007-00007 up to 9% percent Three percent (3%) of securities of the total amount of investments raised in the offering, along the same terms as investors. Common Stock 5000 2.00000 N/A 10000.00 Y Other At issuer's discretion, with priority given to StartEngine Owners 1070000.00 12-16-2022 1.00 153.00 1157.00 153.00 1157.00 0.00 0.00 772225.00 655821.00 1252890.00 1180819.00 0.00 0.00 0.00 0.00 0.00 0.00 -189478.00 -1164009.00 AL AK AZ AR CA CO CT DE DC FL GA HI ID IL IN IA KS KY LA ME MD MA MI MN MS MO MT NE NV NH NJ NM NY NC ND OH OK OR PA PR RI SC SD TN TX UT VT VA WA WV WI WY Sollievo Pharmaceuticals, Inc Robert Schultz CEO, President, Sole Director CFO/Principal Accounting Officer Robert Schultz CEO, President, Sole Director CFO/Principal Accounting Officer 11-15-2022